More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
Moisés Manuel Gallardo‐Pérez, Cesar Homero Gutiérrez‐Aguirre, Juan Carlos Olivares‐Gazca, Guillermo J. Ruíz‐Argüelles
Abstract
host disease.
Topics & Concepts
CyclophosphamideMedicineToxicityImmunosuppressionGraft-versus-host diseaseCytokine release syndromePharmacologyInternal medicineSurgeryTransplantationChemotherapyDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Hematopoietic Stem Cell TransplantationPolyomavirus and related diseasesRenal Transplantation Outcomes and Treatments